Moreover, the function of HAS2 in promoting tumor progression have been demonstrated in pancreatic cancer [21], colorectal cancer [22] etc. However, the regulatory effects and mechanisms of HAS2 in PTC remains to be elucidated. This evidence concerns the gene HAS2 and pancreatic neoplasm.